OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body’s immune system to target and attack cancer.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…
Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…
Did you know that we publish over 3,000 journals, and that over 1,000 of those are clinical science journals? Promote your approved branded drugs and medical devices to our audience…
Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual stories and interactive experiences that connect with people.
Uniphar Group is a trusted global partner to pharmaceutical, medtech, and supply chain and retail companies, working to improve patient access to medicines around the world.
Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that we attend each year.
Company Details
Latest Content from PMHub
Press Releases | October 12, 2026 | Medscape Education
At EHA 2026 in Stockholm, 425 hematologists and oncologists attended an independent, 90-minute Medscape symposium on the practical and ethical use of AI. The format was case-based. The faculty presented...
Press Releases | October 9, 2026 | Genesis Research Group
The publication of the GLOBE Final Rule provides important clarity on the administration's approach to MFN pricing and what it could mean for pharmaceutical pricing, reimbursement, and access strategy globally....
Press Releases | October 8, 2026 | Medscape Education
Disclaimer: Management of migraine in pregnancy typically combines lifestyle strategies, nonpharmacologic approaches, selected pharmacologic options when benefits outweigh risks, and, increasingly, noninvasive neuromodulation technologies.
White Papers and Resources | October 8, 2026 | Inizio
In a recent interview with Pharma Exec, Elaine Ferguson, Global President of Inizio Medical, explores how pharma leadership can support talent development, use AI to augment the workforce, encourage continuous...
White Papers and Resources | October 8, 2026 | Cuttsy + Cuttsy
Explore how pharma can help patients and patient organisations prepare for meaningful involvement in EU HTA without shaping their contribution.
Press Releases | October 5, 2026 | Medscape Education
For more than 30 years, Medscape Education's dedication has been centered on a single goal: building independent, accredited oncology education that improves patient outcomes. This year, at the European Society...
Press Releases | October 2, 2026 | Genesis Research Group
On Tuesday, 6 October 2026, Genesis Research Group’s evidence synthesis, HEOR, and evidence planning teams will be presenting an expert webinar on the topic of selecting the right literature review.
Press Releases | October 1, 2026 | Medscape Education
ICYMI at #AIS2026: using AI in outcomes reporting is a lot like onboarding a research assistant. There's real efficiency in having the help, and a significant amount of background teaching,...
Press Releases | October 1, 2026 | Resonant Group
Global healthcare communications consultancy ANTHEM, a Resonant Group company, today announces the launch of Healthy Influence™, its proprietary methodology that applies the science of influence to healthcare communications.
White Papers and Resources | September 29, 2026 | Cuttsy + Cuttsy
Explore why involving patients early in Joint Scientific Consultations is critical to shaping the outcomes measured in clinical trials.